background


Product Information:

Proxalutamide

Proxalutamide (GT0918) is an orally active potent androgen receptor (AR) antagonist. Proxalutamide (GT0918) can be used in the study for prostate cancer and COVID-19.

Cat. No.: EX-A5434    Purity: >98%
Chemical
Chemical structure of Proxalutamide


For research only, Do not use for Human!

SizeUnit Price (US$)StockQuantityOrder
5mg300In-stock
10mg500In-stock
25mg850In-stock
50mg1200In-stock
100mg1800In-stock
250mg2800In-stock


SynonymsGT0918
CAS No.1398046-21-3
Purity>98%
FormulaC24H19F4N5O2S
Mol Weight517.499
Appearancesolid powder
SolubilitySoluble in DMSO
Shelf Life>2 years if stored properly
StoragePowder -20℃ 2 years; In solvent -20℃ 1 month;
ShippingShipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
 
 
Reference:  [1]. Yang M, et al. Microenvironmental pH-modified solid dispersions to enhance the dissolution and bioavailability of poorly water-soluble weakly basic GT0918, a developing anti-prostate cancer drug: preparation, characterization and evaluation in vivo. Int J Pharm. 2014 Nov 20;475(1-2):97-109.

[2]. Feng Qu, et al. Metabolomic profiling to evaluate the efficacy of proxalutamide, a novel androgen receptor antagonist, in prostate cancer cells. Invest New Drugs. 2020 Oct;38(5):1292-1302.

[3]. Monitoring Editor, et al. Proxalutamide Significantly Accelerates Viral Clearance and Reduces Time to Clinical Remission in Patients with Mild to Moderate COVID-19: Results from a Randomized, Double-Blinded, Placebo-Controlled Trial. Cureus. 2021 Feb; 13(2): e13492.

[4]. Hua Sang, et al. Quantitative determination of proxalutamide in rat plasma and tissues using liquid chromatography/tandem mass spectrometry. Rapid Commun Mass Spectrom. 2021 Feb 15;35(3):e9003.
CoACoA of Proxalutamide

KEYWORDS: buy Proxalutamide | Proxalutamide supplier | purchase | cost | manufacturer | order | distributor | buy 1398046-21-3 | 1398046-21-3 supplier